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Abetrlct
Postpartool depression (PPD) i& a major depressive episode fonowing childbirth 1hat can ha¥e serious consequences affecting the family. Consequences range from marital problems and issues with child
development to maternal suicide and infantlcide. Depressiofl in mothers can lead to cognitive and social impairment in the child 81 well 81
paternal postparlum depression in the father. Due to the seYerity of
these problems, II is important to diagnose and nat mothers as soon
as possible. There are several s~mptoms that are e¥ident in mothers
aufferiog from PPD that lead lo a diagnosis. Symptoms n similar to
1t108e of IR8jor depressi¥t epi8odes, but tfley occur 24 hours to several months poslpartum. Treatment options for PPD include psychotherapy as welt as tricyctic antidepressants and selective serotonin
reuptake inhibitors. While these medications have been shown to be
the most etfecrtve pharmacological options, more researth needs to
be conducted to establish their effects on the infants. The possibilily
of preventative therapy also needs to be addressed to milimize the
long-term e1lects of the disorder.

Introduction
Postpartum depression (PPD) is a major depressive episode in which
onset usually occurs within four weeks of delivery and affects approximately 13 percent of postpartum women. 1•2 This disorder can be
damaging to the mother and the rest of the family. It may result in marital
problems as well as emotional, behavioral and interpersonal problems
in the child subject to this situation. 3 While severe postnatal depression
is easily detected, less severe presentations can be easily dismissed as
normal or natural consequences of childbirth. Failure to recognize postpartum mood disturbances can possibly lead to tragic consequences for
the mother and/or child, most notably maternal suicide and infanticide. 3
Due to these serious consequences, early diagnosis and appropriate
intervention(s) are imperative for the health and well-being of the family.
Symptoms and Risk Factors
Symptoms of postpartum depression, also known as puerperal depression, are listed in Table 1.
Table 1. Symptoms of postpartum depression 1
Fatigue or loss of energy
Depressed mood
Marked loss of interest in most
Feelings of worthlessness
activities
Significant weight loss or gain
Excessive or inappropriate guilt
Insomnia or hypersomnia
Diminished ability to think or concentrate
Psychomotor agitation or retardation Recurrent thoughts of death

Diagnosis requires that five of these symptoms be present during a twoweek period and that at least one of them is either depressed mood or
marked loss of interest in virtually all activities. A woman is at a greater
risk of developing PPD if she was depressed during pregnancy, experienced anxiety or a stressful life event during pregnancy, had low levels of
social support (including marital support), or had a history of depression. 3
Other risk factors for PPD include annual income of less than $20,000,
less than a college education, low occupational prestige, single marital
status and multiple offspring. 5 These issues may be stressors that lead
to increased anxiety and risk of depression. Maternity blues are another
possible predictor of PPD. 6 The blues are described by mild depressive
symptoms, tearfulness, sorrow, unstable moods, anxiety and confusion.
These symptoms usually peak within three to five days after birth and
can last a couple of hours to a couple of weeks. Prevalence of maternity
blues is estimated between 40-60 percent of postpartum women.
Fathers also may experience postpartum depression. The number one
risk factor for paternal postpartum depression is maternal depression.4
Fathers are 2.5 times more likely to become depressed if they have a
depressed partner. If both parents are depressed, this may negatively
impact the development of their child. For men, the most important risk
factor to note is a partner with PPD. Fathers also are at an increased risk
if they have a history of depression or comorbidities, including obsessivecompulsive disorder (OCD) or anxiety. Some possible biologic risk factors include low testosterone, cortisol, vasopressin, or prolactin levels or
dysregulation of estrogen levels. PPD in fathers is also an important area
of study because it can adversely affect the development of the child,
similar to a mother suffering from the illness.

Impact of PPD
In an effort to determine the effects of PPD on an infant, researchers
contacted mothers nine months postpartum who had reported low to high
levels of depression two days after giving birth. 7 There were 100 women
included in the study, 45 percent of whom were first-time mothers. To
eliminate any other contributing factors, the study included only mothers
in stable relationships who were healthy and educated and delivered
a healthy full-term infant. The mothers were divided into three groups:
those who were diagnosed with major depressive disorder at nine months
postpartum (22 mothers), those diagnosed with an anxiety disorder at
nine months postpartum (19 mothers), and those who were not anxious
or depressed nine months postpartum (59 mothers). The study included
two home visits. At the first visit, the mothers were assessed using DSM
IV and self-report measures, while the second visit involved taping the
mothers playing with their infants. The infants were shown increasingly
scary masks to assess fear responses. Saliva samples also were taken
from both the mothers and the infants to assess cortisol levels, a stress
hormone. The infants were evaluated on essential behaviors necessary
for social-emotional growth, including levels of sensitivity, intrusiveness,
social engagement, withdrawal, tear regulation and cortisol reactivity.
The infants with depressed mothers scored the lowest in all of these
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areas. Mothers who are depressed show a decreased sensitivity toward
their infants, which can inhibit social skills that must be learned through
modeling. Sensitivity from the mother, shown by actions such as giving
the child attention and time to rest, helps an infant adapt to a changing
environment. Since the infants of depressed mothers lack this attention,
they are more likely to have an increased fear response and cry more
often. Infants who have not learned to regulate their fear will be more
prone to anxiety disorders in later stages of life.
Achild is more likely to develop improperly if both parents are depressed.4
Research shows that a child raised with unresponsive or chaotic parenting
may have increased cortisol levels, which can hinder brain development,
physiological growth and immune system maturity. The cognitive and
emotional regulation in an infant can be decreased as a result of lack of
maturation of the orbitofrontal cortex due to a poor interaction between
a depressed parent and the infant. Paternal interaction with an infant is
important for a child's cognitive, emotional and social development. Some
explanations for the effects of paternal depression on a child's behavior
include poor father-child interactions, increased marital conflict (indirect
effects), and genetic predisposition.8 Children with depressed fathers show
greater evidence for behavioral and conduct problems, including hyperactivity disorders.4 This relationship seems to be greater in boys than in
girts. Paternal depression also has been associated with low psychosocial
functioning, leading to an elevated suicidal ideation and attempt rates in
sons and depression in daughters. Tests show that paternal depression is
strongly associated with increased risk of high total problem scores on the
Rutter preschool scales and with high scores on the three problem subscales (emotional, conduct and hyperactivity). These problems become
evident in children ages 3 to 5.

Treatment
Treatment and recovery time for postpartum depression (PPD) varies based on the severity of the depression symptoms experienced by
the mother. 9 There are a number of management options available for
women who experience PPD, and, as with many other psychological disorders, it is better to treat the conditions immediately following diagnosis.
Postpartum depression can begin anywhere from 24 hours to several
months after delivery and in some severe cases can last up to two
years. Clinical evidence has shown that sex steroids, like estrogen, have
effects on the areas responsible for mood and cognition in the central
nervous system. 10 When childbirth occurs, there is a rapid drop in estrogen in a woman's body that is thought to trigger depressive symptoms.
Currently, estrogen replacement therapies are being investigated for
possible prophylactic use in some women; however, until more information is available on hormone-based treatments, management for PPD is
still based on non-puerperal depression.
The first line of therapy for a woman experiencing the signs of PPD is
often psychotherapy. 10 This is heavily due to the fact that mothers who
breastfeed want a nonpharmacologic option to avoid exposing their
newborn to antidepressant medications. Counseling from a trained clinical psychologist or psychiatrist is often beneficial for both new mothers
and fathers to find ways to cope with their feelings, solve problems and
set realistic goals for parenting. The partner or the significant other also
should be well-informed of the nature of PPD. While it is beneficial to
support the mother, the significant other may be experiencing depres20
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sion as well due to the anxiety and changing roles that parenting brings.
Knowing that they have someone to talk to can take stress off of both
parents and, in turn, help depression symptoms. For some, marital or
family therapy may be beneficial as well.
For more severe cases of PPD that are not manageable through
psychotherapy alone, there are many antidepressant treatment options
available through prescription. If a mother is finding it difficult to take
care of her baby or herself, or is having thoughts of harming herself
or the child, she should talk to her doctor to weigh the benefits along
with the potential risks of antidepressant therapy. In most cases, the
benefits will outweigh the risks in women with moderate to severe PPD.
The most frequently prescribed antidepressants for both puerperal and
non-puerperal depression have been tricyclic antidepressants, including imipramine, desimipramine, amitriptyline and nortriptyline. 11 These
medications are thought to interfere with the reuptake of norepinephrine
and serotonin. These four agents are all rated by the American Academy
of Pediatrics (AAP) as drugs "of concern" and are not recommended for
use by lactating mothers, although they are not currently contraindicated
by the Food and Drug Administration. 12 However, the selective serotonin
reuptake inhibitors (SSRls), such as fluoxetine, sertraline, paroxetine
and fluvoxamine, which have a higher specificity for blocking serotonin
reuptake, may be better tolerated and have an advantage of once-daily
dosing. 9 The SSRI chosen is an important issue for lactating mothers. In
the case of some SSRls, such as paroxetine and sertraline, although the
agents are excreted in the breast milk, infants are exposed to a relatively
low dose of the drug, with serum concentrations not even detectable
in the children. No adverse effects have been reported, and, although
the medication is considered to be "of concern" due to the excretion of
the drugs, it may be used if it is deemed that the benefits of treatment
outweigh risks to the child. Other SSRls (escitalopram, citalopram)
are excreted in the breast milk in higher quantities than sertraline or
paroxetine, causing the infant to be potentially exposed to a greater
amount of drug. Side effects such as excessive somnolence, decreased
feeding and irritability have been reported in infants exposed to these
medications through breast milk. However, the manufacturers state that
the decision for a breast-feeding mother to use these agents should be
based on risk to the infant versus therapeutic benefit to the mother. The
FDA recommends that fluoxetine not be taken when breastfeeding due
to excretion in the breast milk along with measurable serum concentrations, which can be seen in the child. Colic, slow weight gain and sleep
disorders have been associated with infants exposed to this medication.
As a result, the drug is not recommended by the manufacturer for use in
lactating mothers. 13
As with most antidepressant medications, patients typically show
improvement of symptoms within two to four weeks of starting the medication.9 If no improvement has been seen during the first two weeks of
therapy, the dose of the medication can be increased. Further increasing
of the antidepressant should occur no sooner than seven days after the
last dosage increase. If there is no clinical improvement in six to eight
weeks, the mothers should be referred to a psychiatrist for a psychological evaluation. Although the duration of treatment has not been
specifically established, a rough estimate of nine to 12 months has been
suggested in women experiencing their first episode of PPD.
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Conclusion
Childbirth is a stressful situation that causes many changes in the lives
of the new parents. This new adjustment can cause significant changes
in the mood and behavior of the parents, which may lead to cognitive
and social impairment in the child. Managing the disorder is important for
the mental health of the parents and the development of their children
both emotionally and behaviorally. Tricyclics and SSRls are currently
the most effective pharmacologic treatments for mothers suffering from
PPD. However, more research needs to be conducted to determine the
effect of these medications on the infant and if prevention therapy can
be utilized before the child is born. More studies regarding the effects of
childbirth on men, their potential to develop PPD and possible treatment
options should also be completed.
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